AtriCure, Inc. (ATRC)

NGM – Real vaqt narxi. Valyuta: USD

26.69

+0.39 (1.48%)

Yopilishda: May 12, 2026, 4:00 PM EDT

06.05.2026

AtriCure, Inc. (ATRC) Q1 2026 Earnings Call Transcript

06.05.2026

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q1 Earnings

Although the revenue and EPS for AtriCure (ATRC) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

05.05.2026

AtriCure (ATRC) Reports Break-Even Earnings for Q1

AtriCure (ATRC) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.14 per share a year ago.

05.05.2026

AtriCure Reports First Quarter 2026 Financial Results

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced first quarter 2026 financial results. “Our first quarter results reflect the durability of AtriCure's growth model, fueled by disciplined execution and increased adoption of our innovative products,” said Michael Carrel, President and Chief Executive Officer.

28.04.2026

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming 2026 Bank of America Securities Health Care Conference. AtriCure's management is scheduled to participate in a fireside chat on Tuesday, May 12, 2026, at 10:00 a.m. Pacific Daylight Time. Interested par.

27.04.2026

Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts

Modine Manufacturing led the way during the quarter, benefiting from secular demand in data center cooling and a well received spinoff of Modine Manufacturing's auto cooling business. Coming out of 2025, Adeia reported record revenue and profitability, supported by a surge in IP licensing activity. AtriCure remains well positioned given its first-mover advantage and deep integration within surgical workflows despite near-term competitive concerns from Edwards Lifesciences.

14.04.2026

AtriCure to Announce First Quarter 2026 Financial Results

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026. AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Tuesday, May 5, 2026, to discuss its first quarter financial results. Those interested in listening to th.

Videolar

No Data

There is no data to display

Press-relizlar

05.05.2026

AtriCure Reports First Quarter 2026 Financial Results

28.04.2026

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming 2026 Bank of America Securities Health Care Conference. AtriCure's management is scheduled to participate in a fireside chat on Tuesday, May 12, 2026, at 10:00 a.m. Pacific Daylight Time. Interested par.

24.02.2026

AtriCure to Participate in the Citizens Life Sciences Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Citizens Life Sciences Conference. AtriCure's management is scheduled to participate in a fireside chat on Tuesday, March 10, 2026, at 1:05 p.m. Eastern Time. Interested parties may access a live audio.

17.02.2026

AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced fourth quarter 2025 and full year 2025 financial results. “Our 2025 performance reflects strong execution and continued momentum in our business. We delivered 15% revenue growth for the year and strengthened profitability while advancing key innovation and c.

AtriCure, Inc. (ATRC)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

AtriCure, Inc. (ATRC)

AtriCure, Inc. (ATRC) Q1 2026 Earnings Call Transcript

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q1 Earnings

AtriCure (ATRC) Reports Break-Even Earnings for Q1

AtriCure Reports First Quarter 2026 Financial Results

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts

AtriCure to Announce First Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

AtriCure Reports First Quarter 2026 Financial Results

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

AtriCure to Participate in the Citizens Life Sciences Conference

AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results

AtriCure, Inc. (ATRC) Q1 2026 Earnings Call Transcript

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q1 Earnings

AtriCure (ATRC) Reports Break-Even Earnings for Q1

AtriCure Reports First Quarter 2026 Financial Results

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts

AtriCure to Announce First Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

AtriCure Reports First Quarter 2026 Financial Results

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

AtriCure to Participate in the Citizens Life Sciences Conference

AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results

Search stocks

AtriCure, Inc. (ATRC)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

AtriCure, Inc. (ATRC)

AtriCure, Inc. (ATRC) Q1 2026 Earnings Call Transcript

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q1 Earnings

AtriCure (ATRC) Reports Break-Even Earnings for Q1

AtriCure Reports First Quarter 2026 Financial Results

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts

AtriCure to Announce First Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

AtriCure Reports First Quarter 2026 Financial Results

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

AtriCure to Participate in the Citizens Life Sciences Conference

AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results

AtriCure, Inc. (ATRC) Q1 2026 Earnings Call Transcript

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q1 Earnings

AtriCure (ATRC) Reports Break-Even Earnings for Q1

AtriCure Reports First Quarter 2026 Financial Results

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts

AtriCure to Announce First Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

AtriCure Reports First Quarter 2026 Financial Results

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

AtriCure to Participate in the Citizens Life Sciences Conference

AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results